SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Astec Lifesciences informs about board meeting

19 Oct 2016 Evaluate

Astec Lifesciences has informed that the Meeting of the Board of Directors of the Company is scheduled to be held on October 27, 2016, to consider and approve the Standalone and Consolidated Unaudited Financial results for the Quarter and Half Year ended September 30, 2016 (subject to limited review by the Statutory Auditors of the Company), after these results are reviewed by the Audit Committee.

The above information is a part of company’s filings submitted to BSE.

Astec Lifesciences Share Price

707.35 -19.15 (-2.64%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 656.15
PI Industries 3036.95
Bayer CropScience 4852.90
Sharda Cropchem 1101.50
Sumitomo Chemical 446.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×